Role of STIM1/Orai1-mediated store-operated Ca2+ entry in airway smooth muscle cell proliferation

Division of Respiratory Medicine, Zhongnan Hospital, Wuhan University, Wuhan, China.
Journal of Applied Physiology (Impact Factor: 3.43). 02/2011; 110(5):1256-63. DOI: 10.1152/japplphysiol.01124.2010
Source: PubMed

ABSTRACT Hyperplasia of airway smooth muscle cells (ASMCs) is a characteristic change of chronic asthma patients. However, the underlying mechanisms that trigger this process are not yet completely understood. Store-operated Ca(2+) (SOC) entry (SOCE) occurs in response to the intracellular sarcoplasma reticulum (SR)/endoplasmic reticulum (ER) Ca(2+) store depletion. SOCE plays an important role in regulating Ca(2+) signaling and cellular responses of ASMCs. Stromal interaction molecule (STIM)1 has been proposed as an ER/SR Ca(2+) sensor and translocates to the ER underneath the plasma membrane upon depletion of the ER Ca(2+) store, where it interacts with Orai1, the molecular component of SOC channels, and brings about SOCE. STIM1 and Orai1 have been proved to mediate SOCE of ASMCs. In this study, we investigated whether STIM1/Orai1-mediated SOCE is involved in rat ASMC proliferation. We found that SOCE was upregulated during ASMC proliferation accompanied by a mild increase of STIM1 and a significant increase of Orai1 mRNA expression, whereas the proliferation of ASMCs was partially inhibited by the SOC channel blockers SKF-96365, NiCl(2), and BTP-2. Suppressing the mRNA expression of STIM1 or Orai1 with specific short hairpin RNA resulted in the attenuation of SOCE and ASMC proliferation. Moreover, after knockdown of STIM1 or Orai1, the SOC channel blocker SKF-96365 had no inhibitory effect on the proliferation of ASMCs anymore. These results suggested that STIM1/Orai1-mediated SOCE is involved in ASMC proliferation.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Plasma membrane Ca2+ influx, especially store-operated Ca2+ entry (SOCE) triggered by sarcoplasmic reticulum (SR) Ca2+ release, is a key component of intracellular Ca2+ ([Ca2+]i) regulation in airway smooth muscle (ASM). Agonist-induced Ca2+ oscillations in ASM that involve both influx and SR mechanisms have been previously demonstrated. In non-excitable cells, [Ca2+]i oscillations involve Ca2+ influx via arachidonic acid (AA)-stimulated channels which show similarities to SOCE, although their molecular identity remains undetermined. Little is known about AA-regulated Ca2+ (ARC) channels or their regulation in ASM. In enzymatically-dissociated human ASM cells loaded with the Ca2+ indicator fura-2, AA (1-10μM) triggered [Ca2+]i oscillations that were inhibited by removal of extracellular Ca2+. Other fatty acids such as the diacylglycerol analog OAG, oleic acid and palmitic acid (10μM each) failed to elicit similar [Ca2+]i responses. Pre-incubation with LaCl3 (1μM or 1mM) inhibited AA-induced oscillations. Inhibition of receptor-operated channels (SKF-96365; 10μM), lipoxygenase (zileuton; 10μM) or cyclooxygenase (indomethacin; 10μM) did not affect oscillation parameters. Inhibition of SR Ca2+ release (ryanodine; 10μM, or IP3 receptor inhibitor Xestospongin C; 1μM) decreased [Ca2+]i oscillation frequency and amplitude. siRNA against caveolin-1, STIM1 or Orai3 (20nM each) reduced the frequency and amplitude of AA-induced [Ca2+]i oscillations. In ASM cells derived from asthmatic individuals, AA increased oscillation amplitude but not frequency. These results are highly suggestive of a novel AA-mediated Ca2+ regulatory mechanism in human ASM, reminiscent of agonist-induced oscillations. Given the role of AA in ASM intracellular signaling, especially with inflammation, ARC channels could potentially contribute to increased [Ca2+]i in diseases such asthma.
    American Journal of Respiratory Cell and Molecular Biology 01/2014; DOI:10.1165/rcmb.2013-0144OC · 4.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Plasma membrane Ca(2+)-ATPase (PMCA) plays an important role in regulating intracellular Ca(2+) homeostasis by extruding excessive Ca(2+) to extracellular spaces. PMCA has four isoforms and is widely expressed in different tissues and cells including airway smooth muscle cells (ASMCs). In the present study, we investigated the role of PMCA in the maintenance of Ca(2+) homeostasis and regulation of ASMCs proliferation. By using Ca(2+) fluorescence, we found that inhibition of PMCA with LaCl3 or carboxyeosin (CE) decreased the decay rate of Ca(2+) transient induced by bradykinin (BK). No obvious decay was observed when SERCA was inhibited by thapsigargin (TpG). LaCl3 and CE also induced a spontaneous [Ca(2+)]i increase in the presence of TpG even in Ca(2+)-free bath solution. Both LaCl3 and CE inhibited UTP-induced Ca(2+) oscillations in ASMCs. PCR assay found that PMCA1 and PMCA4 mRNA were expressed in rat ASMCs. The expression of PMCA4 was downregulated in proliferating ASMCs when compared to resting cells. Both the isoform-nonselective PMCA inhibitor caloxin 2a1 and PMCA4-selective inhibitor caloxin 1b1 decreased the decay rate of Ca(2+) transient induced by TpG or BK. PMCA inhibitors except caloxin 2a1 promoted ASMCs proliferation. Annexin-V apoptosis assay detected that caloxin 2a1 increased ASMCs apoptosis, suggesting that inhibition of PMCA with different blockers results in different [Ca(2+)]i and thus different cellular response. Our results provide evidences to support the hypothesis that PMCA is involved in the regulation of Ca(2+) homeostasis and ASMCs proliferation. These data suggest that PMCA may be new targets in the treatment of chronic asthma.
    European Journal of Pharmacology 06/2014; DOI:10.1016/j.ejphar.2014.05.055 · 2.68 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Free calcium ions within the cytosol serve as a key secondary messenger system for a diverse range of cellular processes. Dysregulation of cytosolic Ca2+ handling in airway smooth muscle (ASM) has been implicated in asthma, and it has been hypothesised that this leads, at least in part, to associated changes in both the architecture and function of the lung. Significant research is therefore directed towards furthering our understanding of the mechanisms which control ASM cytosolic calcium, in addition to those regulating the sensitivity of its downstream effector targets to calcium. Key aspects of the recent developments in this field were discussed at the 8th Young Investigators' Symposium on Smooth Muscle (2013, Groningen, The Netherlands), and are outlined in this review.
    Pulmonary Pharmacology &amp Therapeutics 12/2014; 29(2). DOI:10.1016/j.pupt.2014.05.001 · 2.57 Impact Factor